Tian An Medicare 過去の業績
過去 基準チェック /36
Tian An Medicare has been growing earnings at an average annual rate of 5.7%, while the Healthcare industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 6.7% per year. Tian An Medicare's return on equity is 2.4%, and it has net margins of 1.9%.
主要情報
5.7%
収益成長率
5.1%
EPS成長率
Healthcare 業界の成長 | 11.3% |
収益成長率 | 6.7% |
株主資本利益率 | 2.4% |
ネット・マージン | 1.9% |
前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
China Medical & HealthCare Group's (HKG:383) Returns On Capital Not Reflecting Well On The Business
Feb 02Returns On Capital Signal Difficult Times Ahead For China Medical & HealthCare Group (HKG:383)
Oct 26Is China Medical & HealthCare Group (HKG:383) Using Debt In A Risky Way?
Sep 30China Medical & HealthCare Group (HKG:383) Might Have The Makings Of A Multi-Bagger
Dec 10We Think China Medical & HealthCare Group (HKG:383) Has A Fair Chunk Of Debt
Apr 08Do Institutions Own China Medical & HealthCare Group Limited (HKG:383) Shares?
Feb 14Is China Medical & HealthCare Group (HKG:383) A Risky Investment?
Dec 22収支内訳
Tian An Medicare の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
30 Jun 24 | 1,629 | 32 | 229 | 0 |
31 Mar 24 | 1,599 | 21 | 233 | 0 |
31 Dec 23 | 1,569 | 11 | 237 | 0 |
30 Sep 23 | 1,516 | -32 | 246 | 0 |
30 Jun 23 | 1,463 | -78 | 257 | 0 |
31 Mar 23 | 1,450 | -101 | 258 | 0 |
31 Dec 22 | 1,438 | -124 | 259 | 0 |
30 Sep 22 | 1,464 | -115 | 245 | 0 |
30 Jun 22 | 1,491 | -107 | 231 | 0 |
31 Mar 22 | 1,477 | -122 | 228 | 0 |
31 Dec 21 | 1,463 | -137 | 225 | 0 |
30 Sep 21 | 1,447 | -127 | 232 | 0 |
30 Jun 21 | 1,430 | -116 | 238 | 0 |
31 Mar 21 | 1,312 | -114 | 233 | 0 |
31 Dec 20 | 1,194 | -112 | 228 | 0 |
30 Jun 20 | 1,099 | -81 | 238 | 0 |
31 Mar 20 | 1,163 | -40 | 240 | 0 |
31 Dec 19 | 1,228 | 1 | 243 | 0 |
30 Jun 19 | 1,196 | 35 | 246 | 0 |
31 Mar 19 | 1,168 | -8 | 245 | 0 |
31 Dec 18 | 1,139 | -52 | 243 | 0 |
30 Sep 18 | 1,120 | -94 | 246 | 0 |
30 Jun 18 | 1,101 | -137 | 248 | 0 |
31 Mar 18 | 1,115 | -198 | 249 | 0 |
31 Dec 17 | 1,130 | -258 | 249 | 0 |
30 Sep 17 | 1,207 | -165 | 245 | 0 |
30 Jun 17 | 1,284 | -72 | 241 | 0 |
31 Mar 17 | 1,791 | -143 | 251 | 0 |
31 Dec 16 | 2,297 | -214 | 261 | 0 |
30 Sep 16 | 2,349 | -498 | 243 | 0 |
30 Jun 16 | 2,400 | -783 | 225 | 0 |
31 Mar 16 | 1,787 | -375 | 195 | 0 |
31 Dec 15 | 1,175 | 33 | 165 | 0 |
30 Sep 15 | 945 | 131 | 153 | 0 |
30 Jun 15 | 715 | 228 | 141 | 0 |
31 Mar 15 | 859 | 233 | 197 | 0 |
31 Dec 14 | 1,003 | 237 | 253 | 0 |
30 Sep 14 | 1,050 | 582 | 232 | 0 |
30 Jun 14 | 1,096 | 928 | 211 | 0 |
31 Dec 13 | 219 | -363 | -4 | 0 |
質の高い収益: 383 has high quality earnings.
利益率の向上: 383 became profitable in the past.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 383 has become profitable over the past 5 years, growing earnings by 5.7% per year.
成長の加速: 383 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
収益対業界: 383 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.9%).
株主資本利益率
高いROE: 383's Return on Equity (2.4%) is considered low.